Gertrude Nanyonjo, an HPTN 084 Community Working Group member, is the community engagement lead and a senior social sciences coordinator at UVRI-IAVI HIV Vaccine Program in Entebbe, Uganda. She initially worked on an HIV prevention program focusing on youth and adolescents at risk of acquiring HIV in a busy rural center in Southwestern Uganda (Rakai District), where the first HIV case was identified. Nanyonjo has been active in HIV prevention clinical trials and socio-behavioral studies.
Pearson M'modzi is a senior community research officer at UNC Project Lilongwe in Malawi. He has been a lead community educator for the AMP studies (HVTN 703/HPTN 081 and HVTN 704/HPTN 085) and HPTN 084 (LIFE). Pearson also serves as a community working group representative for HPTN 084 and a member of the HPTN Community Working Group Steering Committee.
Doreen Kemigisha, MPH, a member of the HPTN Community Working Group (CWG), is a senior health visitor, community educator, and qualitative coordinator at Makerere University – John Hopkins University (MU-JHU) Research Collaboration based at Mulago Hospital Complex in Kampala, Uganda. She has worked with MU-JHU since 2009, carrying out participant recruitment and retention activities for the HPTN and the Microbicide Trials Network.
Rona Siskind is a health specialist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) in Bethesda, Md., focusing on community engagement, training, and communications related primarily to HIV vaccine and prevention research. She has been at DAIDS for more than 30 years and has worked with all the HIV/AIDS clinical trials research networks. Since early in her tenure at DAIDS, she has worked with, and on behalf of, the networks’ community working groups and advisory boards.